𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Monoclonal antibody-based therapy for neuroblastoma

✍ Scribed by Nai-Kong V. Cheung

Book ID
107546016
Publisher
Current Science Inc.
Year
2000
Tongue
English
Weight
392 KB
Volume
2
Category
Article
ISSN
1523-3790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Monoclonal antibody therapy for lymphoma
Monoclonal antibody therapy for lymphoma
✍ Peter Campbell; Robert Marcus πŸ“‚ Article πŸ“… 2003 πŸ› Elsevier Science 🌐 English βš– 139 KB

Monoclonal antibodies are an exciting advance in the treatment of lymphoma. They are safe and well-tolerated, and exhibit little cross-resistance with conventional chemotherapeutic agents. In indolent lymphomas, antibody therapy has shown useful response rates, both as first-line therapy and in rela

Monoclonal Antibody Therapy for Cancer
Monoclonal Antibody Therapy for Cancer
✍ Mehren, Margaret von; Adams, Gregory P.; Weiner, Louis M. πŸ“‚ Article πŸ“… 2003 πŸ› Annual Reviews 🌐 English βš– 307 KB
Radioimmunodetection of neuroblastoma wi
Radioimmunodetection of neuroblastoma with antineuroblastoma monoclonal antibody
✍ Etoh, Takao ;Takahashi, Hideyo ;Ohnuma, Naomi ;Maie, Masahiko ;Tanabe, Masahiro πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 529 KB

The Antineuroblastoma monoclonal antibody CNM-5 was submitted to preclinical studies and then used for tumor imaging with following results. 1. CNM-5 is an antibody which belongs to the IgM fraction and has a molecular weight of 900 kilodaltons. Its protein concentration was found to be 17.99 mg/dl.